All News

2018

June

Media Release / Jun 19, 2018

Sandoz Canada Becomes the First Canadian Pharmaceutical Company to Enter the Medical Cannabis Field

Read More
Media Release / Jun 07, 2018

Sandoz Canada launches Sandoz Levetiracetam® 1000 mg tablets as an adjunctive treatment of epilepsy

Read More

May

Media Release / May 31, 2018

Community Partnership Day 2018

Read More

April

Media Release / Apr 19, 2018

Four Canadian provinces add Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases

Read More

March

Media Release / Mar 07, 2018

Sandoz Canada launches two new generic therapies for hypertension

Read More

February

Media Release / Feb 06, 2018

Sandoz Canada amongst Top Employers in Montreal

Read More
Media Release / Feb 05, 2018

Quebec adds Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases

Read More

January

Media Release / Jan 09, 2018

Ontario has added ErelziTM (etanercept) to public drug plan for the treatment of multiple inflammatory diseases

Read More
2017

November

Media Release / Nov 16, 2017

British Columbia and Prince Edward Island become the first provinces to add ErelziTM (etanercept) to public drug plans for the treatment of multiple inflammatory diseases

Read More

October

Media Release / Oct 27, 2017

Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Read More

Pages